Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DNAJB7 is a cytoplasmic, evolutionarily conserved molecular chaperone and co-chaperone belonging to the DNAJ/HSP40 family. It stimulates ATPase activity in partner chaperones, and is specifically expressed in the testis at the transcript and protein level, especially in early and late spermatids. DNAJB7 is not essential for spermatogenesis or male fertility in mice, probably due to redundancy among DNAJ family members. It has emerged as a cancer-testis antigen, detectable in certain tumors but absent in most normal tissues except the testis, and is under investigation as a candidate immunotherapy target. DNAJB7’s main function is support of protein folding and quality control under stress conditions, in concert with other heat shock proteins
Not applicable; DNAJB7 is not a current direct therapeutic drug target. For immunotherapy, the mechanism would be immune recognition of cancer cells expressing DNAJB7 (as a cancer-testis antigen)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DnaJ heat shock protein family member B7 (DNAJB7).